Canopy Growth Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Luc Mongeau
- Full Time Employees
- 1,128
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1 Hershey Drive Smiths Falls ON Canada K7A 0A8
- IPO Date
- Apr 7, 2014
- CIK
- 0001737927
- Website
- canopygrowth.com
- Similar Companies
- Business
- Canopy Growth Corporation is a leading global diversified cannabis company engaged in the cultivation, production, and sale of cannabis and cannabinoid-based products. The company offers an extensive portfolio including dried cannabis flower, pre-rolls, oils, softgels, edibles, and beverages, catering to both medical and recreational markets. Its core brands include Tweed, 7ACRES, DOJA, Deep Space, Claybourne, and medical cannabis through its subsidiary Storz & Bickel GmbH & Co. KG, which specializes in cannabis vaporization devices. Canopy operates large-scale GMP-certified indoor and greenhouse cultivation facilities primarily in Canada, with significant operations in the United States, Germany, the United Kingdom, and emerging markets in Australia, Denmark, Peru, and Brazil. Founded in 2013 and headquartered in Smiths Falls, Ontario, Canada, the company focuses on rigorous quality assurance, genetic research, and innovative product development. In the past two years, Canopy Growth has strategically sharpened its operational focus by divesting non-cannabis businesses and adopting an asset-light, brand-driven model to reduce complexity and cost structure. The company has advanced its product innovation with launches such as the advanced all-in-one vape devices featuring CCELL technology under the Tweed and 7ACRES brands to capture demand in premium vaporization formats. Financially, Canopy has improved stability by reducing costs, cash burn, and debt, while targeting positive adjusted EBITDA. It has made significant operational shifts including reallocating its Kelowna DOJA operations towards specialized medical cannabis cultivation and expanding into the wellness market with hemp-derived products under initiatives like Wana Wellness. Canopy also maintains a strategic option to acquire Acreage Holdings in the US, pending federal legalization, positioning it for accelerated entry into the American cannabis market. Canopy Growth's comprehensive range of cannabis products, global geographic footprint, and recent emphasis on operational efficiency and innovation underpin its role as a market leader in the cannabis industry. The company continues to focus on premium and mainstream cannabis products designed to improve lives while pursuing growth through strategic partnerships, focused market expansion, and advanced product offerings. It employs approximately 960 people and reported revenue growth and margin improvements in its Canadian cannabis segment amid ongoing cost reduction efforts. Its headquarters remain at 1 Hershey Drive, Smiths Falls, Ontario.
Company News
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today
Can Canopy Growth Survive Another 5 Years?
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Canopy Growth Corporation (NASDAQ:CGC) Stock Now Rated “Hold” by Sell-Side Analysts
Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock?
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?